Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223221097331
Abstract: Introduction: Intravenous immunoglobulin (IVIG) was reported to be the third most used monotherapy in livedoid vasculopathy (LV). There is currently a lack of randomized controlled clinical trials and no standardized therapeutic regimen for IVIG therapy… read more here.
Keywords: systematic review; efficacy safety; intravenous immunoglobulin; ivig therapy ... See more keywords
Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults.
Sign Up to like & getrecommendations! Published in 2019 at "International heart journal"
DOI: 10.1536/ihj.18-299
Abstract: The efficacy of intravenous immunoglobulin (IVIG) in the treatment of acute myocarditis remains controversial. The aim of this study was to conduct a meta-analysis to assess the efficacy of IVIG in children and adults with… read more here.
Keywords: intravenous immunoglobulin; children adults; myocarditis; acute myocarditis ... See more keywords
The EIF2AK4/rs4594236 AG/GG Genotype Is a Hazard Factor of Immunoglobulin Therapy Resistance in Southern Chinese Kawasaki Disease Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.868159
Abstract: Background: Kawasaki disease (KD) is an acute, self-limited vasculitis disorder of unknown etiology in children. Immunologic abnormalities were detected during the acute phase of KD, which reflected that the effect cells of the activated immune… read more here.
Keywords: kawasaki disease; therapy; rs4594236 genotype; resistance ... See more keywords